# EDGAR Filing Document

**Accession Number:** 0001731348
**File Stem:** 0001140361-23-002453
**Filing Date:** 2023-1
**Character Count:** 3819
**Document Hash:** e543e4922abf53c2a86afebc190e5b17
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-23-002453.hdr.sgml**: 20230124

**ACCESSION NUMBER**: 0001140361-23-002453

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230124

**DATE AS OF CHANGE**: 20230123

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tilray Brands, Inc.
- **CENTRAL INDEX KEY:** 0001731348
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 824310622
- **FISCAL YEAR END:** 0531

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38594
- **FILM NUMBER:** 23545475

**BUSINESS ADDRESS:**
- **STREET 1:** 655 MADISON AVENUE
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065
- **BUSINESS PHONE:** 519.322.8800

**MAIL ADDRESS:**
- **STREET 1:** 655 MADISON AVENUE
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10065

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Tilray, Inc.
- **DATE OF NAME CHANGE:** 20180213

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### SCHEDULE 14A

#### (Rule 14a-101)

#### INFORMATION REQUIRED IN PROXY STATEMENT

#### SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ **Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

☐ Definitive Proxy Statement

&nbsp;&nbsp;&nbsp;&nbsp;☒ Definitive Additional Materials

☐ Soliciting Material Pursuant to §240.14a-12

---

| |
|:---|
| **Tilray Brands, Inc.** |
| (Name of Registrant as Specified in its Charter) |

---

<u><br> </u> <br> (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):

&nbsp;&nbsp;&nbsp;&nbsp;☒ No fee required.

☐ Fee paid previously with preliminary materials.

☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![](image00002.jpg)

#### Tilray needs you to act.VOTE "FOR" PROPOSAL 3 TODAY — PROTECT YOUR VOTING RIGHTS
Tilray needs you to act. VOTE "FOR" PROPOSAL 3 TODAY — PROTECT YOUR VOTING RIGHTS Today, every share of stock that we have issued has one vote per share, but our Certificate of Incorporation provides that we could issue a super-voting class of stock. We want to eliminate that out-of-date concept.You and all our current and future shareholders benefit if we ensure that all shareholders of common shares have equal voting rights, or one vote per share, and we need your vote to make this amendment to our Charter. This proposal will have no impact on your rights as a Class 2 shareholder. All rights of the common shareholders, including voting rights, will remain intact and unchanged, and the Charter Amendment will not dilute existing shareholders. *We have had to adjourn our Annual Meeting to February 15, 2023.* So please vote "FOR" Proposal 3 today and protect your voting rights. If you have already voted, but voted against the proposal, we urge you to consider changing your vote to "FOR". **If you have any questions, or need any assistance in voting your shares, please contact Morrow Sodali LLC at (800) 449-0910 toll-free in the U.S. and Canada or (203) 658-9400 or by email at TLRY@info.morrowsodali.com.** 

<br> VOTE BY INTERNET Go to ProxyVote.com and enter the Control Number found on your voting instruction form to vote your shares. VOTE BY PHONE Call 1-800-690-6903 at any time. Please have your Control Number ready. VOTE BY MAIL Mark, sign and date your ballot and return it in the postage-paid envelope provided.

------